According to Jefferies, Insulet PODD reported 2Q sales of $32.2mn, largely in-line with expectations.
Jefferies said that full year guidance was narrowed to $152-158mn from $150-160mn. “Op expenses took a step up on the Neighborhood integration, but the company remains on track to reach operating cash breakeven by year end.”
Insulet closed yesterday at $18.44.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in